Back to Newsroom
Back to Newsroom

The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of CAG, HCSG and ARA

Thursday, 18 April 2019 10:05 AM

The Klein Law Firm

Topic:
Lawsuits

NEW YORK, NY / ACCESSWIRE / April 18, 2019 / The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. If you suffered a loss you have until the lead plaintiff deadline to request that the court appoint you as lead plaintiff.

Conagra Brands, Inc. (NYSE: CAG)
Class Period: Purchasers of common stock between June 27, 2018 and December 19, 2018, including legacy Pinnacle Foods, Inc. common stock holders who received Conagra stock in exchange for their Pinnacle shares; and shareholders who purchased shares pursuant and/or traceable to Conagra's SPO on or about October 9, 2018
Lead Plaintiff Deadline: April 23, 2019

The lawsuit alleges that throughout the class period, Conagra Brands, Inc. made materially false and/or misleading statements and/or failed to disclose that: (i) Conagra inadequately performed proper due diligence in connection with the acquisition of Pinnacle; (ii) the performance of Pinnacle's three leading brands was not deteriorating due to intensified competition, but to self-inflicted subpar innovation and executional missteps; (iii) Pinnacle's business was performing so poorly that it had resorted to pushing promotional deals to retailers in an effort to boost sales; and (iv) as a result of the foregoing, Defendant's public statements were materially false and/or misleading and/or lacked a reasonable basis when made.

Get additional information about the CAG lawsuit: http://www.kleinstocklaw.com/pslra-1/conagra-brands-inc-loss-submission-form?wire=3.

Healthcare Services Group, Inc. (NASDAQ: HCSG)
Class Period: April 11, 2017 to March 4, 2019
Lead Plaintiff Deadline: May 21, 2019

The lawsuit alleges that Healthcare Services Group, Inc. made materially false and/or misleading statements and/or failed to disclose that: (a) Defendant Wahl either knew or was reckless in not knowing that the Company had been accused of strategically rounding quarterly earnings per share, and therefore investors could not rely upon the Company's track record without conducting a thorough investigation into the allegations; (b) Defendants concealed that the SEC had written to the Company in November 2017 to inquire into the Company's earnings per share rounding practices; and (c) the Company concealed that the SEC delivered a subpoena to the Company in March 2018 demanding the Company produce documents in connection with how it calculated earnings per share.

Get additional information about the HCSG lawsuit: http://www.kleinstocklaw.com/pslra-1/healthcare-services-group-inc-loss-submission-form?wire=3.

American Renal Associates Holdings, Inc. (NYSE: ARA)
Class Period: August 10, 2016 to March 27, 2019
Lead Plaintiff Deadline: May 28, 2019

The complaint alleges that during the class period American Renal Associates Holdings, Inc. made materially false and/or misleading statements and/or failed to disclose that: (1) issues with American Renal's accounting process for revenue recognition, collections, and related matters would give rise to a U.S. Securities and Exchange Commission ("SEC”) investigation into the same, and increased regulatory scrutiny by the SEC; (2) financial statements for the fiscal years 2014, 2015, 2016 and 2017 contained in its Annual Reports for the years ended December 31, 2016 and 2017, and its condensed consolidated financial statements in quarterly reports from 2016 through 2018, were false and could not be relied upon; (3) American Renal had material weaknesses in its internal control over financial reporting; and (4) as a result, defendants' public statements were materially false and misleading at all relevant times.

Get additional information about the ARA lawsuit: http://www.kleinstocklaw.com/pslra-1/american-renal-associates-holdings-inc-loss-submission-form?wire=3.

Your ability to share in any recovery doesn't require that you serve as a lead plaintiff. There is no cost or obligation to you. If you suffered a loss during the class period and wish to obtain additional information, please contact J. Klein, Esq. by telephone at 212-616-4899 or visit the webpages provided.

J. Klein, Esq. represents investors and participates in securities litigations involving financial fraud throughout the nation. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:

J. Klein, Esq.
Empire State Building
350 Fifth Avenue
59th Floor
New York, NY 10118
[email protected]
Telephone: (212) 616-4899
Fax: (347) 558-9665
www.kleinstocklaw.com

SOURCE: The Klein Law Firm

Topic:
Lawsuits
Back to newsroom
Back to Newsroom
Share by: